Team

Phone +49 621/383-71314
eva.altrock@remove-this.medma.uni-heidelberg.de

• Improvement of MDS modelling
• 3D Ossicle model as an alternative method
• 3D in vitro cell culture of MDS MSCs and HSPCs
• (PhD student: cand. med. Ann-Christin Belzer)

Phone +49 621/383-71304
nanni.schmitt@remove-this.medma.uni-heidelberg.de

• Generation of MDS models to be used as pre-clinical platforms, and their further optimization
• Pre-clinical assessment of NK cell based therapies for treatment of AML and high-risk MDS
• PhD students: cand. med. Alexandra Beck, Teresa Klink und Meret Hahn

Phone +49 621/383-71310

vladimir.ryabov@remove-this.medma.uni-heidelberg.de

• Role of MSC/HSC crosstalk in the pathogenesis of myeloid neoplasms (MDS and MPN), molecular studies (Vladimir Riabov and Alessa Klär) 
• Generation of preclinical models to therapeutically target AML/immune cell crosstalk (Vladimir Riabov)
• R-loops mediated replication stress as a novel therapeutic target in MDS with splicing factor mutations (Vladimir Riabov and MD student: Marie Demmerle)
• Investigation of the role of BM microenvironment in MDS (Vladimir Riabov and Alessa Klär)

Phone +49 621/383-711303

alessa.klaer@remove-this.medma.uni-heidelberg.de

• Role of MSC/HSC crosstalk in the pathogenesis of myeloid neoplasms (MDS and MPN), molecular studies (Vladimir Riabov and Alessa Klär) 
• Investigation of the role of BM microenvironment in MDS (Vladimir Riabov and Alessa Klär)

Phone +49 621/383-71314 or -4115

alexander.streuer@remove-this.medma.uni-heidelberg.de

• Next Generation Sequencing (RNA sequencing, whole exome sequencing, single-cell RNA sequencing)
• Pipelines for the analysis of clonal alterations of leukemic cells
• “Radiomics”- the role of spatial sampling for Contact: therapy decisions and outcome

Phone +49 621/383-71314

felicitas.rapp@remove-this.medma.uni-heidelberg.de

• Management of research projects
• Administration of funding
• Preparation of new clinical studies
• Coordination of ongoing studies